Lupin gets CDSCO Panel nod for Rifapentine Dispersible Tablet 150 mg
New Delhi: Granting the local clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved drug major Lupin’s Rifapentine dispersible Tablets 150mg for already approved indication with the condition of conducting a Phase IV Clinical study. This came after the firm presented their proposal for a […]